NCT06955104View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia

PHASE3CompletedINTERVENTIONAL

Enrollment

145

Participants

Timeline

Start Date

April 3, 2025

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2025

Conditions

Dyslipidemia

Interventions

DRUG

JW0108 + C2407

JW0108 + C2407

DRUG

JW0108 + C2407 placebo

JW0108 + C2407 placebo

Trial Locations (1)

05505

Asan Medical Center, Seoul

Sponsors

Lead Sponsor

JW Pharmaceutical

All Listed Sponsors

lead

JW Pharmaceutical

INDUSTRY

NCT06955104 - Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia | Biotech Hunter | Biotech Hunter